Comparative Evaluation of Effects of Oral Diltiazem and Topical Diltiazem (2%) Ointment in the Treatment of Chronic Anal Fissure: A Prospective Randomized Study.

Q3 Medicine Middle East Journal of Digestive Diseases Pub Date : 2024-07-01 Epub Date: 2024-07-31 DOI:10.34172/mejdd.2024.383
Ekta Sharma, Pankaj Dugg, Nisha Rani, Vivek Pahuja, Sushil Kumar Mittal, Harnam Singh Rekhi
{"title":"Comparative Evaluation of Effects of Oral Diltiazem and Topical Diltiazem (2%) Ointment in the Treatment of Chronic Anal Fissure: A Prospective Randomized Study.","authors":"Ekta Sharma, Pankaj Dugg, Nisha Rani, Vivek Pahuja, Sushil Kumar Mittal, Harnam Singh Rekhi","doi":"10.34172/mejdd.2024.383","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fissure-in-Ano is a common condition of the anorectal region. Most of the time, it is managed non-surgically. There are various drugs used for the treatment of anal fissures. Calcium channel blockers are one of them that reduce the tone of sphincter muscles. The present study compares the efficacy of oral diltiazem and topical 2% diltiazem ointment in patients with chronic anal fissures.</p><p><strong>Methods: </strong>Patients were randomized into two groups. Group A (n=25) received treatment in the form of oral diltiazem, while group B (n=25) received treatment in the form of 2% (weight/volume) diltiazem ointment for local application in addition to other conservative methods like sitz bath and stool softeners. Outcomes in the form of success of treatment and complications were assessed. Statistical analysis was done using MedCalc software version 14.0. <i>P</i> value of<0.05 was considered significant.</p><p><strong>Results: </strong>The mean age of patients was 32.00±10.67 years in group A and 30.64±9.53 years in group B. Pain relief was significantly better in group B than in group A at the end of the first week (<i>P</i>=0.00018), but at the end of 6th week, no significant difference was observed. Fissure healing was more significant in group B than in group A after 6 weeks (<i>P</i>=0.0152).</p><p><strong>Conclusion: </strong>Local diltiazem ointment is a better option than oral diltiazem for anal fissures with respect to better outcomes and lesser complications.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"16 3","pages":"160-165"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459288/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Middle East Journal of Digestive Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/mejdd.2024.383","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fissure-in-Ano is a common condition of the anorectal region. Most of the time, it is managed non-surgically. There are various drugs used for the treatment of anal fissures. Calcium channel blockers are one of them that reduce the tone of sphincter muscles. The present study compares the efficacy of oral diltiazem and topical 2% diltiazem ointment in patients with chronic anal fissures.

Methods: Patients were randomized into two groups. Group A (n=25) received treatment in the form of oral diltiazem, while group B (n=25) received treatment in the form of 2% (weight/volume) diltiazem ointment for local application in addition to other conservative methods like sitz bath and stool softeners. Outcomes in the form of success of treatment and complications were assessed. Statistical analysis was done using MedCalc software version 14.0. P value of<0.05 was considered significant.

Results: The mean age of patients was 32.00±10.67 years in group A and 30.64±9.53 years in group B. Pain relief was significantly better in group B than in group A at the end of the first week (P=0.00018), but at the end of 6th week, no significant difference was observed. Fissure healing was more significant in group B than in group A after 6 weeks (P=0.0152).

Conclusion: Local diltiazem ointment is a better option than oral diltiazem for anal fissures with respect to better outcomes and lesser complications.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
口服地尔硫卓和外用地尔硫卓(2%)软膏治疗慢性肛裂效果的比较评估:前瞻性随机研究。
背景:肛裂是肛门直肠部位的一种常见病。大多数情况下,都可以通过非手术治疗。有多种药物可用于治疗肛裂。钙通道阻滞剂是其中一种能降低括约肌张力的药物。本研究比较了口服地尔硫卓和外用 2% 地尔硫卓软膏对慢性肛裂患者的疗效:方法:将患者随机分为两组。方法:患者被随机分为两组,A 组(25 人)接受口服地尔硫卓的治疗,B 组(25 人)除了接受坐浴和软便剂等其他保守治疗方法外,还接受局部涂抹 2%(重量/体积)地尔硫卓软膏的治疗。对治疗的成功率和并发症进行了评估。统计分析使用 MedCalc 软件 14.0 版进行。结果A组患者的平均年龄为(32.00±10.67)岁,B组患者的平均年龄为(30.64±9.53)岁。在第一周结束时,B组患者的疼痛缓解情况明显优于A组(P=0.00018),但在第六周结束时,未观察到明显差异。6周后,B组的裂口愈合比A组明显(P=0.0152):结论:局部地尔硫卓软膏比口服地尔硫卓治疗肛裂效果更好,并发症更少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Middle East Journal of Digestive Diseases
Middle East Journal of Digestive Diseases Medicine-Gastroenterology
CiteScore
1.20
自引率
0.00%
发文量
33
审稿时长
12 weeks
期刊最新文献
Altered Cytokine Production in Patients with Helicobacter pylori Infection. Celiac Crisis: A Life-Threatening Complication of Celiac Disease. Correlation between Autoimmune Hashimoto's Thyroiditis and Helicobacter pylori Infection: A Case-Control Study. Developing Mobile Health Applications for Inflammatory Bowel Disease: A Systematic Review of Features and Technologies. Ulcerative and Cytomegalovirus Colitis Associated with Fournier's Gangrene: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1